70 results match your criteria: "Newcastle Upon Tyne Hospitals Trust[Affiliation]"
Int J Radiat Oncol Biol Phys
January 2025
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Purpose: Osteoradionecrosis of the jaw (ORNJ) is a severe iatrogenic disease characterized by bone death after radiation therapy (RT) to the head and neck. With over 9 published definitions and at least 16 classification systems, the true incidence and severity of ORNJ are obscured by lack of a standard for disease definition and severity assessment, leading to inaccurate estimation of incidence, reporting ambiguity, and likely under-diagnosis worldwide. This study aimed to achieve consensus on an explicit definition and phenotype of ORNJ and related precursor states through data standardization to facilitate effective diagnosis, monitoring, and multidisciplinary management of ORNJ.
View Article and Find Full Text PDFBlood Cancer J
August 2024
Dana-Farber Cancer Institute, Boston, MA, USA.
Purpose: Osteoradionecrosis of the jaw (ORNJ) is a severe iatrogenic disease characterized by bone death after radiation therapy (RT) to the head and neck. With over 9 published definitions and at least 16 diagnostic/staging systems, the true incidence and severity of ORNJ are obscured by lack of a standard for disease definition and severity assessment, leading to inaccurate estimation of incidence, reporting ambiguity, and likely under-diagnosis worldwide. This study aimed to achieve consensus on an explicit definition and phenotype of ORNJ and related precursor states through data standardization to facilitate effective diagnosis, monitoring, and multidisciplinary management of ORNJ.
View Article and Find Full Text PDFJ Laryngol Otol
April 2024
Clinical Oncology, Ipswich Hospital, East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK.
Am J Cardiol
November 2023
Department of Cardiology, Freeman Hospital, Newcastle Upon Tyne Hospitals Trust, Newcastle upon Tyne, United Kingdom; Institute of Biosciences, Newcastle University, Newcastle upon Tyne, United Kingdom. Electronic address:
Oncol Ther
September 2023
NCCC, Newcastle Upon Tyne Hospitals Trust, Newcastle Upon Tyne, UK.
Introduction: Extrapolating long-term overall survival (OS) from shorter-term clinical trial data is key to health technology assessment in oncology. However, extrapolation using conventional methods is often subject to uncertainty. Using ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor T-cell therapy for multiple myeloma, we used a flexible Bayesian approach to demonstrate use of external longer-term data to reduce the uncertainty in long-term extrapolation.
View Article and Find Full Text PDFBlood Cancer J
January 2023
Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Multiple myeloma (MM) is an incurable blood cancer that primarily affects older adults. Several frailty tools have been developed to address the heterogeneity of aging in this population. Uptake of these measures has been variable, leading to a gap in knowledge regarding the proportion of enrolled trial participants considered frail and uncertainty in the treatment-related effects and outcomes among this high-risk population.
View Article and Find Full Text PDFBMC Pulm Med
November 2022
Royal Victoria Infirmary, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
Introduction: Dysphagia occurs in multiple respiratory pathophysiologies, increasing the risk of pulmonary complications secondary to aspiration. Reflux associated aspiration and a dysregulated lung microbiome is implicated in Idiopathic Pulmonary Fibrosis (IPF), but swallowing dysfunction has not been described. We aimed to explore oropharyngeal swallowing in IPF patients, without known swallowing dysfunction.
View Article and Find Full Text PDFAm J Surg Pathol
January 2023
Department of Pathology, The Johns Hopkins Hospital.
While amoebic infection is widely known as a cause of gastroenteritis, keratitis, and meningoencephalitis, amoebae are challenging to recognize at unexpected sites. Despite multiple case reports of sinonasal amoebiasis, amoebic infection is not regularly considered in the differential diagnosis of sinonasal necroinflammatory disease. Here, we aim to characterize the pathologic features of sinonasal amoebiasis to facilitate better recognition.
View Article and Find Full Text PDFBJU Int
April 2022
British Urology Researchers in Surgical Training (BURST), London, United Kingdom.
Objective: To evaluate the status of UK undergraduate urology teaching against the British Association of Urological Surgeons (BAUS) Undergraduate Syllabus for Urology. Secondary objectives included evaluating the type and quantity of teaching provided, the reported performance rate of General Medical Council (GMC)-mandated urological procedures, and the proportion of undergraduates considering urology as a career.
Materials And Methods: LEARN was a national multicentre cross-sectional study.
Pathogens
March 2022
University of Bordeaux, National Institute for Health and Medical Research (INSERM), Research Institute for Sustainable Development (IRD), Bordeaux Population Health Research Centre, Team GHiGS, 33000 Bordeaux, France.
ERJ Open Res
April 2022
North East Assisted Ventilation Service, Newcastle Upon Tyne Hospitals Trust, Newcastle, UK.
Introduction: increases morbidity and mortality in respiratory disease. To date the long-term ventilation population does not have clear guidelines regarding its management.
Method: We undertook a retrospective observational study in a regional long-term ventilation population (837 patients).
Clin Chest Med
March 2022
Population and Health Science Institute, National Institute for Health Research Biomedical Research Centre, Newcastle University and Regional Bronchiectasis Centre, Newcastle Upon Tyne Hospitals Trust, Newcastle, Tyne and Wear, UK. Electronic address:
The bronchiectasis and chronic obstructive pulmonary disease (COPD) overlap syndrome (BCOS) is increasingly recognized. BCOS is associated with poorer outcomes and increased mortality than in either disease alone. In the following article, the authors discuss why COPD and bronchiectasis might coexist, the radiological issues in diagnosing bronchiectasis in COPD, the understanding of prevalence and the factors that impact this, mortality and morbidity, microbiology associations, and the impact BCOS has on investigations and management.
View Article and Find Full Text PDFClin Infect Dis
September 2022
Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Introduction: The chest radiograph (CR) remains a key tool in the diagnosis of pediatric tuberculosis (TB). In children with presumptive intrathoracic TB, we aimed to identify CR features that had high specificity for, and were strongly associated with, bacteriologically confirmed TB.
Methods: We analyzed CR data from children with presumptive intrathoracic TB prospectively enrolled in a cohort study in a high-TB burden setting and who were classified using standard clinical case definitions as "confirmed," "unconfirmed," or "unlikely" TB.
Lancet Haematol
December 2021
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Patients with multiple myeloma frequently present with substantial immune impairment and an increased risk for infections and infection-related mortality. The risk for infection with SARS-CoV-2 virus and resulting mortality is also increased, emphasising the importance of protecting patients by vaccination. Available data in patients with multiple myeloma suggest a suboptimal anti-SARS-CoV-2 immune response, meaning a proportion of patients are unprotected.
View Article and Find Full Text PDFBMC Public Health
October 2021
Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, Birmingham, UK.
BMC Public Health
August 2021
Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.
Background: Little is known about modifiable dietary and physical activity risk factors for cardiovascular diseases (CVDs) in Sierra Leone. This information is critical to the development of health improvement interventions to reduce the prevalence of these diseases. This cross-sectional study investigated the prevalence and socio-demographic correlates of dietary and physical activity risk behaviours amongst adults in Bo District, Sierra Leone.
View Article and Find Full Text PDFAge Ageing
November 2021
Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Berlin, Germany.
Background: older people remain underrepresented in clinical trials, and evidence generated in younger populations cannot always be generalized to older patients.
Objective: to identify key barriers and to discuss solutions to specific issues affecting recruitment and retention of older participants in clinical trials based on experience gained from six current European randomised controlled trials (RCTs) focusing on older people.
Methods: a multidisciplinary group of experts including representatives of the six RCTs held two networking conferences and compiled lists of potential barriers and solutions.
BMJ
March 2021
Department of Medicine, University of Auckland, Auckland 1142, New Zealand.
Kidney Int Rep
January 2021
Division of Molecular & Clinical Medicine, School of Medicine, Ninewells Hospital, University of Dundee, Dundee, UK.
Introduction: Increased left ventricular mass index (LVMI) is associated with mortality in end-stage renal disease. LVMI regression may improve outcomes. Allopurinol has reduced LVMI in randomized controlled trials in chronic kidney disease, diabetes, and ischemic heart disease.
View Article and Find Full Text PDFNeurodegener Dis Manag
February 2021
Department of Neurology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
The transition from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis (SPMS) remains a clinical challenge owing to the heterogeneous course of the disease, indistinct disease progression and lack of availability of validated biomarkers and diagnostic tools. This article summarizes the outcomes from an international expert group meeting conducted to validate the preliminary research findings gathered through interviews with primary healthcare stakeholders and pharmaceutical representatives, and to understand the current and future patient journey of SPMS across seven European countries. We highlight the uncertainty in SPMS diagnosis and management and, consequently, the need for uniform assessment guidelines, enhanced awareness and a collaborative effort between the stakeholders associated with SPMS patient care and the pharmaceutical industry.
View Article and Find Full Text PDFClin Kidney J
June 2020
AGE Research Group, NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle-upon-Tyne Hospitals Trust, Newcastle, UK.
Background: Improving recognition of patients at increased risk of acute kidney injury (AKI) in the community may facilitate earlier detection and implementation of proactive prevention measures that mitigate the impact of AKI. The aim of this study was to develop and externally validate a practical risk score to predict the risk of AKI in either hospital or community settings using routinely collected data.
Methods: Routinely collected linked datasets from Tayside, Scotland, were used to develop the risk score and datasets from Kent in the UK and Alberta in Canada were used to externally validate it.
Leukemia
January 2021
Erasmus MC Cancer Institute, Erasmus University of Rotterdam, Rotterdam, The Netherlands.
Vaccination is one of the most successful medical interventions that has saved the life of millions of people. Vaccination is particularly important in patients with multiple myeloma, who have an increased risk of infections due to the disease-inherent immune suppression, and because of the immune suppressive effects of therapy. Hence, all appropriate measures should be exploited, to elicit an effective immune response to common pathogens like influenza, pneumococci, varicella zoster virus, and to those bacteria and viruses (haemophilus influenzae, meningococci, and hepatitis) that frequently may pose a significant risk to patients with multiple myeloma.
View Article and Find Full Text PDFBackground: Effective treatment for patients at least 70 years with newly diagnosed glioblastoma remains challenging and alternatives to conventional cytotoxics are appealing. Autophagy inhibition has shown promising efficacy and safety in small studies of glioblastoma and other cancers.
Methods: We conducted a randomized phase II trial to compare radiotherapy with or without hydroxychloroquine (2:1 allocation).